StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.19+0.05 (+4.39%)

Close on Nov 20, 2026Market cap $8.56MP/E 0.8Yield –

Chemomab Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Chemomab Therapeutics

Chemomab Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Chemomab Therapeutics figures

See a number that looks wrong?